[Coordinated management of arterial hypertension]

Area of Science:

• Cardiology
• Nephrology
• Internal Medicine

Context:

• Arterial hypertension management remains challenging despite therapeutic advancements and poly-pill options.
• Resistant hypertension often requires multidisciplinary care involving internal medicine, nephrology, and cardiology specialists.
• Current treatment guidelines recommend ACEI/ARA2, thiazide-like diuretics, and calcium channel blockers as reference triple therapy.

Purpose:

• To review the current landscape of arterial hypertension control.
• To highlight the emerging role of renal denervation in managing resistant hypertension.
• To discuss the potential integration of renal denervation into future clinical guidelines.

Summary:

• Despite numerous treatments, hypertension control is inadequate, necessitating multidisciplinary approaches.
• Resistant hypertension cases often fail to respond to standard triple therapy (ACEI/ARA2, thiazide-like diuretic, CCB).
• Recent studies indicate renal denervation effectively lowers blood pressure, offering a new therapeutic avenue.

Impact:

• Renal denervation may become a key strategy for improving blood pressure control in resistant hypertension.
• The integration of renal denervation into guidelines could enhance treatment options and patient outcomes.
• This technique has the potential to significantly advance the management of arterial hypertension globally.